| 821 | GCP clinical trial | | 18/11/2021 22:03:16 | |
| 822 | GCP involving drugs | | 18/11/2021 22:04:10 | |
| 823 | GCP US FDA | | 18/11/2021 22:04:46 | |
| 824 | RCR | | 18/11/2021 22:05:33 | |
| 825 | gcp | | 18/11/2021 22:06:26 | |
| 826 | GCP | | 19/11/2021 08:12:12 | |
| 827 | CITI | | 19/11/2021 14:21:57 | |
| 828 | GCP | | 19/11/2021 15:12:32 | |
| 829 | RCR for IRB members, Researchers, Faculty members | | 19/11/2021 20:04:57 | |
| 830 | IRB members, Researchers, Faculty members - Basic/Refresher | | 19/11/2021 20:05:40 | |
| 831 | Conflicts of Interest for IRB members, Researchers, Faculty members | | 19/11/2021 20:06:07 | |
| 832 | GCP (ICH Focus) for IRB members, Researchers, Faculty members | | 19/11/2021 20:07:01 | |
| 833 | Good clinical practice (CITI program) | | 19/11/2021 21:11:32 | |
| 834 | citi GCP | | 20/11/2021 11:31:45 | |
| 835 | citi GCP1 | | 20/11/2021 11:32:33 | |
| 836 | CITI program | | 20/11/2021 12:25:51 | |
| 837 | CITI program | | 20/11/2021 12:26:26 | |
| 838 | CITI program | | 20/11/2021 12:26:48 | |
| 839 | CITI program | | 20/11/2021 12:27:07 | |
| 840 | CITI program | | 20/11/2021 12:27:36 | |
